pivotal trial

MAPLE GROVE, Minn., June 30, 2026 Francis Medical announced the publication of initial results from its VAPOR 2 pivotal...

JERUSALEM, May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its ReSTART pivotal clinical...

WHITE BEAR LAKE, MINNESOTA, UNITED STATES — February 17, 2026 Envoy Medical announced that enrollment in its pivotal clinical...

WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...

Dateline Introduction Shanghai, China & Cambridge, Massachusetts — November 17, 2025 — YolTech Therapeutics has received FDA Investigational New...

DALLAS, Oct. 2, 2025 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to TSHA-102,...